Is NMN Legal in Europe? Novel Food Status, Explained Honestly

Search “is NMN legal in Europe” and you will be handed two confident answers, both wrong. One says yes, because you can find it for sale; the other says no, because it has been “banned.” Neither is the real picture. NMN’s status is not a verdict but a frame: the question that actually decides legality is what NMN is being sold as. Get that distinction right and the rest follows cleanly.

What does the EU say NMN actually is?

In food law, NMN has a defined status: it is a Novel Food. That is not marketing language and not an insult — it is a legal classification under Regulation (EU) 2015/2283, the regulation governing foods without a meaningful history of consumption in the Union.² The test is a single date. A food counts as “novel” if it was not consumed to a significant degree within the EU before 15 May 1997, and the burden of proving prior consumption falls on the business that wants to sell it.²

For NMN, that burden has not been met. An official European Commission consultation request — addressed to the Czech competent authority and circulated to Member States — states the position plainly: NMN “is considered a novel food,” placed in category 3(2)(a)(i), because “a history of consumption prior to 15 May 1997 has not been established in the EU.”¹ So the first half of the answer is settled and verifiable: as a food, NMN is a Novel Food in the European Union.

So is it legal to sell NMN as a supplement?

Here is the consequence most articles skip. Novel Food status is not a label you can simply attach and proceed; it is a gate. Under Regulation (EU) 2015/2283, a novel food may not be placed on the EU market until it has passed a safety assessment, been authorised by the Commission, and added to the Union list of authorised novel foods.² Authorisation first, sale second — not the other way around.

As of mid-2026, NMN has not cleared that gate. There is no NMN entry on the Union list. That means selling NMN as a food supplement across the EU is, on the face of the regulation, not yet lawful — regardless of how widely it may circulate in practice.² The honest one-line summary is uncomfortable for the supplement market: NMN is a recognised Novel Food that has not yet been authorised as one.

NMN is a recognised Novel Food in the EU — and, as of 2026, an unauthorised one. Both halves of that sentence are true at the same time, and that tension is the whole story.

But didn’t EFSA just approve NMN?

This is where the picture is genuinely moving, and where careful reading earns its keep. In May 2026 the European Food Safety Authority published a scientific opinion on β-nicotinamide mononucleotide — EFSA Journal 2026;24(5):e10007 — concluding that the specific NMN ingredient it assessed is safe at the proposed conditions of use.³ The opinion frames NMN in part as a source of nicotinamide (vitamin B3) and addresses its bioavailability in the context of the food-supplements Directive 2002/46/EC.³

The crucial distinction is between an opinion and an authorisation. EFSA does not authorise anything; it assesses risk and advises. A positive EFSA opinion is a necessary step, not the finish line. The European Commission and Member States must still vote to authorise the ingredient and write it into the Union list before it can lawfully be sold as a supplement.³² A favourable scientific verdict in May does not put a product on a shelf in June.

NMN in the EU food regime, stage by stage: recognised, assessed, but not yet authorised or listed. The answer to “is it legal?” depends entirely on which row you are pointing at.

Whose NMN, exactly? Why “approved” is applicant-specific

A subtlety the headlines flatten: Novel Food authorisations are tied to dossiers, not to molecules in the abstract. The EFSA opinion concerned a particular applicant’s NMN, manufactured and characterised in a particular way, at a particular proposed use level.³ The Commission’s public record shows that more than one company has applied — for instance, a summary application from SyncoZymes (Shanghai) Co., Ltd. requests authorisation for NMN in food supplements at up to 500 mg/day.⁴ The use levels and applicants differ from dossier to dossier.

This matters because, under the regulation, newly generated safety data can be subject to data protection, meaning an initial authorisation may be available to a specific applicant before becoming a generic, open authorisation any business can rely on.² “NMN was approved” can therefore be true for one company’s ingredient and false for another’s at the very same moment. Anyone making a blanket legality claim about “NMN” has skipped the question of whose NMN, made how, and listed where.

15 May 1997 the cut-off date that defines a Novel Food — and the line NMN sits on the wrong side of, which is why none of this is optional.²

Where does Research Use Only NMN fit?

Everything above concerns NMN as a food. There is a second, entirely separate frame: NMN supplied as a Research Use Only reference material. An RUO reagent is not a food and not a medicine. It is a characterised compound for in-vitro and laboratory work, explicitly not authorised, intended, or sold for human or veterinary consumption. Because it is not placed on the market as food, the Novel Food authorisation question does not apply to it in the same way — the food regime governs foods, and an RUO reagent is, by definition, not one.

That is not a loophole; it is a different category with its own obligations. The instant a “research” material is offered, labelled, or described for human consumption, it leaves reagent territory and walks straight into the food (or, depending on the claims, the medicines) regime it was never authorised for. The RUO frame is honest precisely because it is narrow: it is the legality of a laboratory reference material, and it evaporates the moment the intended use changes. If you want the science underneath the regulation, start with what NMN actually is and what the human evidence on NAD, NMN and NR really shows.

What about athletes and anti-doping?

A fourth frame, owing nothing to food law, applies to anyone governed by the World Anti-Doping Code. NMN is not named on the 2026 WADA Prohibited List.⁵ But “not named” is not “cleared.” WADA’s S0 clause sweeps in substances with no current regulatory approval for human therapeutic use, and the Code’s strict-liability principle makes an athlete responsible for whatever is detected in their body — irrespective of how a supplier labelled the vial.⁵ The sport frame is separate from the food frame; a competitor must reckon with both, and a “supplement” or “RUO” tag is no defence in a doping case.

What is the honest bottom line?

Three things, stated without the usual confidence theatre. First, NMN is a Novel Food in the EU — that part is settled and documented.¹ Second, as a food supplement it is not yet authorised: EFSA’s positive 2026 opinion moved the process forward, but the Commission-and-Member-State vote and the Union-list entry have not happened, so the lawful-to-sell-as-food question is, today, “not yet.”³² Third, the situation is in active transition and applicant-specific, so any snapshot — including this one — ages, and you should check the current Union list rather than trust a date-stamped claim.

This article is informative, not legal advice. Novel Food status is decided at EU level, but national enforcement and rules differ, and only qualified counsel in your own jurisdiction can tell you what applies to you. What does not change is the distinction that runs through the whole question: a food supplement and a Research Use Only reference material are two different things under two different bodies of law. Everything Condor Research supplies in this category is the latter — a characterised NMN research reference material, sold strictly for research use only, not authorised or intended for human consumption, and not a recommendation to use any compound. Knowing which frame you are standing in is the first step to answering “is it legal” honestly.

This article is informative and is not legal advice. Condor Research supplies characterised research reference materials strictly for Research Use Only — for in-vitro and laboratory research. Nothing supplied is an approved or authorised food, supplement, or medicine, none of it is intended for human or veterinary use, and nothing here is a recommendation to consume any compound.

Condor Research · Scientific desk